Position in ZYME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,800,390
+$88,811 QoQ
Shares Held
145,386
-1.9% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#40
of 202 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. ZYME ranks #40 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in ZYME
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,800,390 | 145,386 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,711,579 | 148,226 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,831,910 | 145,534 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,501,195 | 146,440 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,844,272 | 146,954 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,623,559 | 136,319 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,048,911 | 139,953 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,801,929 | 143,580 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,238,392 | 145,522 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,623,888 | 154,362 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,621,193 | 156,034 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,005,999 | 158,675 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $733,786 | 84,929 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $709,432 | 78,477 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $616,420 | 78,425 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $482,123 | 78,394 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||